Jade Biosciences, Inc. (NASDAQ: JBIO) announced the dosing of the first participant in its Phase 2 JUNIPER clinical trial on May 26, 2026. This essential…
IDEAYA Biosciences (NASDAQ: IDYA) saw its shares surge 27% on Monday after the company announced positive topline results from a pivotal clinical trial. The Phase…
March 16, 2026
Cogent Biosciences Secures FDA Acceptance for Rare Blood Disorder Treatment Application
Cogent Biosciences Inc. (NASDAQ: COGT) achieved a critical regulatory milestone today. The U.S. Food and Drug Administration (FDA) officially accepted the company’s New Drug Application…
Clinical-stage pharmaceutical company, Artelo Biosciences, Inc. (Nasdaq: ARTL), has been named a finalist in Johnson & Johnson’s (NYSE: JNJ) Innovation Challenge in dermatology. The event…